Blog
Product strategy, conversion systems, and telehealth operations for teams building modern care journeys.
Hims Sells TRT Now: How an Independent Testosterone Brand Competes, With the DEA Deadline 7 Weeks Out
On October 21, 2026 Hims added three testosterone products to the low-T program it opened in September 2025: a compounded twice-weekly injection, generic testosterone cypionate, and Kyzatrex, an FDA-approved oral capsule, all behind an at-home lab test and a live provider visit. That takes away the easy differentiator of 'we test first.' Here is what an independent TRT brand can still own, and what to have ready for December 31, when the DEA telemedicine flexibilities expire with no final rule and no extension published as of early November.
Reducing Refunds + Chargebacks in Subscription Telehealth
Chargebacks are rarely about fraud. They usually happen when onboarding, billing, or communication breaks. Here’s how to fix the workflow and keep revenue predictable.
How to Reduce Drop-Off in Telehealth Onboarding (Real Funnel Checklist)
A practical checklist to identify and fix the biggest drop-off points in your telehealth patient onboarding funnel.
A/B Testing for Telehealth: What to Test on Landing Pages and Intake Flows
Learn which elements to test on your telehealth landing pages and intake flows to maximize conversions and patient acquisition.